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ABSTRACT: The purpose of the study was to estimate prevalence of medication non-
compliance among adolescents, following discharge from hospital. A second purpose
was to identify predictors of such noncompliance. Seventy-one adolescents, who had
been prescribed a medication during psychiatric hospitalization, were interviewed by
telephone, 6-8 months post-hospitalization. Medication noncompliance was defined
as discontinuing medication without the recommendation of the treating physician.
Twenty-four subjects (33.8%) were noncompliant with medication. Age, race, gender,
SES, diagnosis, type and number of medications, severity of depression, and family
living arrangement did not predict noncompliance. We concluded that noncompliance
with psychotropic medications was relatively common and difficult to predict in adoles-
cents who had been hospitalized to a psychiatric inpatient unit; the majority of them
suffered from depression. Clinicians should be aware that medication noncompliance
may be common and a relatively unpredictable phenomenon.
KEY WORDS: Adolescence; Medication; Noncompliance.
Introduction
Medication compliance among adolescents with psychiatric disor-
ders is an understudied area. Studies involving medically ill patients
have indicated that adolescents, compared to other age groups, may
be at the highest risk for medication noncompliance.1,2 A medication
noncompliance rate of 60% has been reported in a mixed preadoles-
cent and adolescent group of 54 outpatients with attention deficit hy-
peractivity disorder.3,4 A more recent study of adolescents, a large
number of whom were substance abusers (47%), found a 62% noncom-
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pliance rate at 14 months following discharge from psychiatric hospi-
talization. With the exception of a few recent studies, most studies of
noncompliance among child psychiatric populations have focused on
psychotherapy as a treatment modality and noncompliance with med-
ication has been left largely unexplored.5,6 Although findings from
psychosocial treatments may generalize to other treatment modal-
ities, study of psychotropic medication noncompliance is likely to have
distinct clinical implications.
The definition of noncompliance and study-methods used for its es-
timation are fraught with controversy. Compliance has been defined
as "the extent to which the patient's behavior coincides with the clini-
cal prescription."7 Study-methods employed to measure compliance
and treatment follow-through have included direct estimation of med-
ication in body fluids, pill count, self-report interview, estimation
based on treatment outcome, and estimation based on assessment of
the treating physician. Each method has advantages and disadvan-
tages.8,9 For instance, body fluid measurement is costly and impracti-
cal. Pill count method is susceptible to multiple problems such as
patient failure to bring the pill container, errors caused by the phar-
macist, and the fact that the patient may discard pills prior to the
visit.8 The pill-count method, compared with body fluid estimates,
was found to over-estimate medication compliance by approximately
10%.9 Self-report interview techniques have the advantage of being
the least expensive method, those who report noncompliance rarely
lie, and this method may identify those noncompliant individuals
most susceptible to interventions for improving compliance.7 However,
this technique has the disadvantage of over-estimating compliance.10
To our knowledge, medication noncompliance in the post-hospital-
ization period among adolescents with psychiatric disorders has never
been examined with the exception of a recent study which involved a
large number of patients with substance abuse disorders." In the pre-
sent study, we examined the influence of psychiatric diagnosis, num-
ber of medications prescribed, type of prescribed medication, severity
of depression, and demographic variables. The present study involved
a structured telephone follow-up questionnaire. This was the most
feasible approach because study participants were recruited from a
university hospital with a large catchment area (majority of follow-up
care was provided in outlying centers) which precluded a more direct
measurement (i.e. pill count; body fluid level estimation). It should be
noted that previous studies have documented comparable findings
from telephone and in-person interviews using a structured instru-
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ment.11 Finally, we believed that adolescents might find a self-report
telephone interview relatively nonthreatening. We hypothesized that
adolescents who had been psychiatrically hospitalized at a university
medical center would be at high risk for noncompliance with psycho-
tropic medications. Noncompliance was defined as discontinuing med-
ication without the recommendation of the treating physician. Con-
versely, compliance was defined as either continuing medication at
the time of the follow-up, or discontinuing medication based on rec-
ommendation of the treating physician.
Methods
Subjects were 71 adolescents (Table 1) who had been hospitalized to the
Adolescent Psychiatry Inpatient Program at a university hospital and were
prescribed a psychotropic medication. Majority of patients, 31 (54.9%), were
recommended one medication. Many patients had failed treatment prior to
hospitalization resulting in frequent use of mood stabilizers and neuroleptics.
The small numbers of stimulants prescribed in the present study reflect that
attention deficit disorder was rarely the presenting problem. Subjects were
distributed across social classes I-IV.12 Each subject received a comprehensive
diagnostic evaluation: a clinical interview; a computerized diagnostic inter-
view using the Diagnostic Interview Schedule for Children (DISC-2.3).13 psy-
choeducational evaluation; milieu observation; and routine laboratory investi-
gations. Standardized rating scales completed during assessment were the
Children's Depression Rating Scale-Revised (CDRS);14 Reynolds Adolescent
Depression Rating Scale (RADS);15 and Suicidal Ideation Questionnaire (SIQ-
JR).16 Admission CDRS-R = 52.6 ± 14.3; admission SIQ-Jr = 26.4 ±25.1; admis-
sion RADS = 71.8±17.4; and follow-up RADS = 67 ± 16.8; follow-up SIQ-
Jr = 21.2 ± 18.8. Prior to discharge, parental written consent and assent of the
adolescent were obtained for a follow-up telephone interview.
The sections in the follow-up interview pertinent to the study were: 1) name
of the medication; 2) whether the medication was discontinued on recommen-
dation of a physician; 3) reason for discontinuation (side-effects, recovery from
illness, perceived lack of efficacy); and 4) current living situation. Questions
were administered to both the parent (or a responsible adult) and the adoles-
cent. Final answers were based on clinical judgment, using information from
both respondents.
Because of sample size limitations, diagnostic and medication categories
were created for the analyses. Diagnostic categories were based on DSM-III-R
(APA, 1987);17 medication categories were consistent with standard classifica-
tion principles used in psychopharmacology. Depressive Disorders (DD: major
depression, dysthymia, depressive disorder-NOS), Anxiety Disorders (AD:
panic disorder with/without agoraphobia, simple phobia, social phobia, OCD,
PTSD, generalized anxiety disorder, separation anxiety disorder), Disruptive
Behavior Disorders (DBD; attention deficit hyperactivity disorder, conduct
disorder, oppositional defiant disorder, alcohol and substance use disorders).
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In addition, the Depressive Disorders group was subcategorized into Depres-
sion with Comorbidity and Depression Without Comorbidity (DEP-nocomor-
bid) subgroups. Because of a relatively small sample size and preliminary
nature of the study, it was not feasible to analyze compliance for all possible
diagnostic or medication subgroups. Therefore, we compared subjects with
depression versus those who did not have depression, anxiety disordered pa-
tients versus those who did not have an anxiety disorder, disruptive behavior
disordered patients versus those with no disruptive behavior disorders, and
depression with comorbid anxiety/behavior disorder versus depression with-
out comorbid disorders (no comobid anxiety or behavior disorder). Com-
orbidity was common and diagnoses per subjects were 1.79 ± .81 (mean±SD).
Medication categories compared were Antidepressants (serotonin reuptake
inhibitors, tricyclic antidepressants, tetracyclics, bupropion, venlafaxine,
Table 1





Mean number of medications
per patient
Length of hospitalization





F = 40, M = 31
14.9 ±1.4 years
Caucasian = 62(87.3%)





Biological parents = 27(37.7)
Single parents =15(14.4%)
Biological + step =15(21. 7%)
Non-parent = 14(20.2%)
Depressive Disorders = 55(77. 5%)
(depression with comorbid anxiety/
behavior disorders = 44, depression
with no comorbid anxiety or /dis-
ruptive behavior =11)
Disruptive Behavior = 40(56.3%)
Anxiety Disorder = 32(45. 7%)
Antidepressants = 58 (62%)
Mood stabilizers = 16(17%)
Neuroleptic= 18(19%)
Stimulants = 2(2%)
*Many subjects received more than one diagnosis and were prescribed more that one
medication
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trazodone) versus no antidepressants, Mood Stabilizers (lithium, valproate,
carbamazepine) versus no mood stabilizers, Neuroleptics versus no neurolep-
tics, Tricyclic (TCA) antidepressants versus no TCAs, and non-tricyclics (Non-
TCA; included selective serotonin reuptake inhibitors) to those not on non-
TCAs.
Noncompliance was defined categorically as discontinuation of medication
without recommendation of a physician. Compliance was defined as either
continuing treatment with the medication, or discontinuing it on a recommen-
dation made by a physician. Noncompliant subjects were compared with com-
pliant subjects using chi-square, t-test, or analysis of variance as appropriate.
Variables examined were age, race, gender, SES, diagnoses, severity of de-
pression, length of hospitalization, type and number of medications, and fam-
ily living arrangement (both biological parents, single parent, one step and
one biological parents, a non-parent).
Results and Discussion
Out of the entire group of 71 patients, 42 (59.2%) subjects had dis-
continued their medication at the time of follow-up. But only 24
(33.8%) subjects met criteria for noncompliance as defined for this
study, i.e. the medication was stopped without recommendation of a
physician. Therefore, the noncompliance rate was 33.8%. All refer-
ences to noncompliant patients involved this sub-group. Since the ma-
jority of subjects in our sample suffered from some type of depressive
disorder, our findings are most relevant to this patient population.
Reasons given by the noncompliant group were side-effects = 30%(7),
perceived recovery = 10%(2), perceived lack of efficacy = 20%(5), and
other = 40%( 10). The mean number of medications recommended per
patient was = 1.5 ±0.6. The interval between discharge and follow-up
was approximately 6-8 months (mean in weeks = 30.4 ±6.7). Mean
number of follow-up appointments with a psychiatrist/family physi-
cian for medication management was 5.4 ±6.
In the overall sample, noncompliance could not be predicted based
on diagnosis, type of medication, number of medications, severity of
depression, age, race, gender, SES, or family living arrangement. Ab-
sence of an association between demographic variables and noncom-
pliance is consistent with previous studies.7 The present study design
did not measure patient-attitude toward psychotropic medications
which may significantly influence medication compliance.19 Also, par-
ent-child relationship factors could not be evaluated; findings from
other studies indicate that absence of hostility and affective-related-
ness with a parent may significantly improve medication compliance.18,10
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Lack of association with depression severity was probably a result of
high mean depression score for the entire group.
In comparison to subjects without depressive disorders, the fifty-
five patients (77.5%) diagnosed with a Depressive Disorder were pre-
scribed significantly fewer number of medications. The Depressive
Disordered group was prescribed a significantly fewer number of
medications compared to non-depressed subjects (mean = 1.4 vs. 1.8;
t(df=18.7)= -1.8, p<.05). However, the proportion of noncompliant
subjects in the two groups did not differ. There was also no difference
in the noncompliance rate between the two distinct sub-groups: de-
pression with comorbidity versus DEP-nocomorbid.
Thirty-two (45.7%) patients were diagnosed with one or more Anxi-
ety Disorders, which was usually comorbid with another Axis I disor-
der (30 out of 32 were comorbid). There was no difference in the num-
ber of medications prescribed for this group, and the noncompliance
rate did not differ when compared with subjects with no anxiety dis-
orders.
Forty (56.3%) subjects met diagnostic criteria for a Disruptive Be-
havior Disorder. There was no difference in the number of medica-
tions prescribed for this group, and no difference in the noncom-
pliance rate compared with patients without a Disruptive Behavior
Disorder. Although we had anticipated a greater noncompliance rate
in the DBD, this was not found to be true. We believe that because of
high prevalence of comorbidity, the impact of individual disorders
could not be fully elicited. The effect of bipolar mood disorder and
schizophrenia could not be examined because of the small number of
subjects (4 and 2 respectively).
Our findings have several clinical and research implications. First,
because we used a conservative definition of noncompliance, the ac-
tual rate of noncompliance may far exceed the one reported here. Sec-
ond, there appears to be a lack of relationship between type of medi-
cation and noncompliance, therefore, the issue of noncompliance must
be addressed for all types of medication efficacy studies involving psy-
chotropic medications. Third, when lack of response to a psychotropic
agent is encountered in clinical practice, the high possibility of non-
compliance and methods to improve adherence to medication must be
considered before implementing any medication changes. Finally,
given the unpredictability of medication noncompliance behavior, pre-
ventive measures to ensure greater compliance must be directed at
all psychiatrically ill adolescents.
Drawbacks of the present study include a relatively small sample
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size; reliance on patient self-report measure of noncompliance and
lack of direct methods for confirming medication compliance (exam-
ination of body fluids); variability induced by different treating clini-
cians and treatment settings at the time of follow-up; a variable time
interval between discharge from hospital and follow-up; a relatively
homogeneous diagnostic group which did not allow for comparison
with other diagnoses; patient attitude toward medication was not
measured, and the relationship between the adolescent and an adult
living in the home could not be measured. Despite these drawbacks,
findings of the present study are an important contribution to an un-
derstudied area of psychopharmacology. Based on our findings, it
would thus appear that noncompliance with psychotropic medications
is common and difficult to predict. A high index of suspicion for non-
compliance is warranted and methods known to be associated, at
least anecdotally, with higher compliance rates (i.e., patient educa-
tion and least effective dosing to minimize side-effects) should be uni-
versally incorporated in medication management of all adolescent
psychiatric patients. Future research on medication compliance should
include direct methods for estimation of medication compliance, mea-
surement of patient and parental attitudes toward medication, and
measurement of factors, which reflect parent-child relationship.
Summary
Using telephone follow-up method, we found that a little over a
third of adolescents hospitalized 6-9 months earlier to an acute psy-
chiatry inpatient unit were noncompliant with their psychotropic
medications. Noncompliance was defined as discontinuing a medica-
tion without input from a treating physician. Majority of patients suf-
fered from a Depressive Disorder, therefore, the study findings are
most relevant to this group. Given the conservative nature of our defi-
nition of noncompliance, a higher noncompliance rate may be ex-
pected in clinical practice. Demographic variables, diagnoses, severity
of depression, or the type and number of prescribed medications could
not predict noncompliance. We concluded that noncompliance with
psychotropic medications is common, difficult to predict, preventive
measures should be directed at all psychiatrically ill adolescents, and
should be suspected when encountering lack of response to a psycho-
tropic agent. Implications for clinical practice and future study direc-
tion are discussed.
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